RadNet, Inc. (RDNT) Stock

RadNet, Inc. operates as a leading provider of outpatient diagnostic imaging services across the United States, offering a comprehensive range of advanced medical imaging modalities. Established in 1981, RadNet and its subsidiaries specialize in magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and various multi-modality imaging services.

In addition to its imaging services, RadNet is actively involved in the development and sale of computerized systems tailored for the diagnostic imaging industry. These systems include picture archiving communications systems (PACS) and associated services, aimed at optimizing workflow efficiency and diagnostic accuracy. Moreover, the company is at the forefront of integrating artificial intelligence (AI) into radiology practices. RadNet has deployed AI suites specifically designed to assist radiologists in interpreting mammography images, as well as developing AI solutions focused on enhancing diagnostic capabilities for lung and prostate cancers.

As of December 31, 2021, RadNet owned and managed an extensive network of 347 outpatient imaging centers strategically located across several states, including Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. This expansive network ensures broad accessibility to high-quality imaging services for patients nationwide.

Headquartered in Los Angeles, California, RadNet, Inc. continues to lead the diagnostic imaging sector through its commitment to technological innovation, comprehensive service offerings, and a robust network of imaging centers aimed at meeting the diverse needs of healthcare providers and patients alike.